Design, synthesis, and Multivariate quantitative structure-activity relationship of Salicylanilides-Potent inhibitors of type III secretion in Yersinia

被引:65
作者
Dahlgren, Markus K. [1 ]
Kauppi, Anna M. [1 ]
Olsson, Ing-Marie [1 ]
Linusson, Anna [1 ]
Elofsson, Mikael [1 ]
机构
[1] Umea Univ, Dept Chem, S-90187 Umea, Sweden
关键词
D O I
10.1021/jm070741b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analogues to the salicylanilide N-(4-Chlorophenyl)-2-acetoxy-3,5-diiodobenzamide, 1a, an inhibitor of type III secretion (T3S) in Yersinia, were selected, synthesized, and biologically evaluated in three cycles. First, a set of analogues with variations in the salicylic acid ring moiety was synthesized to probe possible structural variation. A basic structure-activity relationship was established and then used to cherry-pick compounds from a principal component analysis score plot of salicylanilides to generate a second set. A third set with increased likelihood of biological activity was designed using D-optimal onion design. A quantitative structure-activity relationship model using hierarchical partial least-square regression to latent structures (Hi-PLS) was computed using PLS score vectors of building blocks correlated to the % inhibition of T3S as a response. A PLS discriminant analysis (PLS-DA) model was derived using the same descriptor set as that for the Hi-PLS model. Both models were validated with an external test set.
引用
收藏
页码:6177 / 6188
页数:12
相关论文
共 58 条
[1]   Bacterial virulence as a target for antimicrobial chemotherapy [J].
Alksne, LE ;
Projan, SJ .
CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (06) :625-636
[2]  
[Anonymous], 2004, MOE
[3]   Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle [J].
Bailey, Leslie ;
Gylfe, Asa ;
Sundin, Charlotta ;
Muschiol, Sandra ;
Elofsson, Mikael ;
Nordstrom, Peter ;
Henriques-Normark, Birgitta ;
Lugert, Raimond ;
Waldenstrom, Anders ;
Wolf-Watz, Hans ;
Bergstrom, Sven .
FEBS LETTERS, 2007, 581 (04) :587-595
[4]  
Barrett J. F., 1995, ANNU REP MED CHEM, P111
[5]   Robust Salmonella metabolism limits possibilities for new antimicrobials [J].
Becker, D ;
Selbach, M ;
Rollenhagen, C ;
Ballmaier, M ;
Meyer, TF ;
Mann, M ;
Bumann, D .
NATURE, 2006, 440 (7082) :303-307
[6]  
BRUNDTLAND GH, 2000, OVERCOMING ANTIMICRO
[7]   New technologies for high-throughput screening [J].
Burbaum, JJ ;
Sigal, NH .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (01) :72-78
[8]  
*CAMBRIDGESOFT, 2002, CHEMACX2002
[9]   Molecular and cell biology aspects of plague [J].
Cornelis, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :8778-8783
[10]   The Yersinia Yop virulon: A bacterial system for subverting eukaryotic cells [J].
Cornelis, GR ;
WolfWatz, H .
MOLECULAR MICROBIOLOGY, 1997, 23 (05) :861-867